The immune system activator interleukin-2 helps 15% of advanced melanoma cases and cures a few, but it produces such devastating side effects that patients must be hospitalized.

FORBES: Targeting Melanoma

The best treatments up to now, interleukin-2 or interferon-alpha, help only 15% of patients.

FORBES